STRYKER CORP Selling, General and Administrative Expense
STRYKER CORP (SYK) reported Selling, General and Administrative Expense of $2.23 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-07-31
- STRYKER CORP selling, general and administrative expense for the quarter ending 2026-06-30 was $2.23B, a 7.22% increase year-over-year.
- STRYKER CORP selling, general and administrative expense for the quarter ending 2026-03-31 was $2.28B, a 0.83% decline year-over-year.
- STRYKER CORP selling, general and administrative expense for the quarter ending 2025-12-31 was $2.23B, a 4.90% increase year-over-year.
- STRYKER CORP selling, general and administrative expense for the quarter ending 2025-09-30 was $2.04B, a 7.97% increase year-over-year.
- STRYKER CORP selling, general and administrative expense for fiscal 2025 was $8.65B, a 12.57% increase from fiscal 2024.
- STRYKER CORP selling, general and administrative expense for fiscal 2024 was $7.68B, a 8.07% increase from fiscal 2023.
- STRYKER CORP selling, general and administrative expense for fiscal 2023 was $7.11B, a 11.35% increase from fiscal 2022.
- STRYKER CORP selling, general and administrative expense for fiscal 2022 was $6.39B, a 0.64% decline from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.23B 10-Q · filed 2026-07-31 | $4.51B 10-Q · filed 2026-07-31 | $6.74B derived: sum of 3 quarters · filed 2026-07-31 | $8.78B derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2026-03-31 | $2.28B 10-Q · filed 2026-05-11 | $4.51B derived: sum of 2 quarters · filed 2026-05-11 | $6.55B derived: sum of 3 quarters · filed 2026-05-11 | $8.63B derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-12-31 | $2.23B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $4.27B derived: sum of 2 quarters · filed 2026-02-11 | $6.35B derived: sum of 3 quarters · filed 2026-07-31 | $8.65B 10-K · filed 2026-02-11 | ||||
| 2025-09-30 | $2.04B 10-Q · filed 2025-10-31 | $4.12B derived: sum of 2 quarters · filed 2026-07-31 | $6.42B 10-Q · filed 2025-10-31 | $8.55B derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-06-30 | $2.08B 10-Q · filed 2026-07-31 | $4.38B 10-Q · filed 2026-07-31 | $6.50B derived: sum of 3 quarters · filed 2026-07-31 | $8.40B derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-03-31 | $2.30B 10-Q · filed 2026-05-11 | $4.42B derived: sum of 2 quarters · filed 2026-05-11 | $6.32B derived: sum of 3 quarters · filed 2026-05-11 | $8.15B derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $2.12B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $4.02B derived: sum of 2 quarters · filed 2026-02-11 | $5.85B derived: sum of 3 quarters · filed 2026-02-11 | $7.68B 10-K · filed 2026-02-11 | ||||
| 2024-09-30 | $1.89B 10-Q · filed 2025-10-31 | $1.90B 10-Q · filed 2024-10-30 | $3.73B derived: sum of 2 quarters · filed 2025-10-31 | $5.56B 10-Q · filed 2025-10-31 | $5.58B 10-Q · filed 2024-10-30 | $7.47B derived: sum of 4 quarters · filed 2026-02-11 | ||
| 2024-06-30 | $1.83B 10-Q · filed 2025-08-01 | $1.85B 10-Q · filed 2024-07-31 | $3.67B 10-Q · filed 2025-08-01 | $3.69B 10-Q · filed 2024-07-31 | $5.58B derived: sum of 3 quarters · filed 2026-02-11 | $7.29B derived: sum of 4 quarters · filed 2026-02-11 | ||
| 2024-03-31 | $1.84B 10-Q · filed 2025-05-02 | $1.84B 10-Q · filed 2024-05-01 | $3.75B derived: sum of 2 quarters · filed 2026-02-11 | $5.46B derived: sum of 3 quarters · filed 2026-02-11 | $7.17B derived: sum of 4 quarters · filed 2026-02-11 | |||
| 2023-12-31 | $1.91B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $3.62B derived: sum of 2 quarters · filed 2026-02-11 | $5.33B derived: sum of 3 quarters · filed 2026-02-11 | $7.11B 10-K · filed 2026-02-11 | $7.13B 10-K · filed 2024-02-14 | |||
| 2023-09-30 | $1.71B 10-Q · filed 2024-10-30 | $1.70B 10-Q · filed 2023-11-03 | $3.42B derived: sum of 2 quarters · filed 2024-10-30 | $5.20B 10-Q · filed 2024-10-30 | $5.19B 10-Q · filed 2023-11-03 | $6.88B derived: sum of 4 quarters · filed 2025-02-12 | ||
| 2023-06-30 | $1.71B 10-Q · filed 2024-07-31 | $1.71B 10-Q · filed 2023-08-04 | $3.49B 10-Q · filed 2024-07-31 | $3.49B 10-Q · filed 2023-08-04 | $5.17B derived: sum of 3 quarters · filed 2025-02-12 | $6.63B derived: sum of 4 quarters · filed 2025-02-12 | ||
| 2023-03-31 | $1.78B 10-Q · filed 2024-05-01 | $3.46B derived: sum of 2 quarters · filed 2025-02-12 | $4.92B derived: sum of 3 quarters · filed 2025-02-12 | $6.46B derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | $1.68B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $3.14B derived: sum of 2 quarters · filed 2025-02-12 | $4.68B derived: sum of 3 quarters · filed 2025-02-12 | $6.39B 10-K · filed 2025-02-12 | $6.46B 10-K · filed 2023-02-10 | |||
| 2022-09-30 | $1.46B 10-Q · filed 2023-11-03 | $2.99B derived: sum of 2 quarters · filed 2023-11-03 | $4.70B 10-Q · filed 2023-11-03 | $6.45B derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | $1.54B 10-Q · filed 2023-08-04 | $3.25B 10-Q · filed 2023-08-04 | $4.99B derived: sum of 3 quarters · filed 2024-02-14 | $6.60B derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | $1.71B 10-Q · filed 2023-05-02 | $3.46B derived: sum of 2 quarters · filed 2024-02-14 | $5.06B derived: sum of 3 quarters · filed 2024-02-14 | $6.56B derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-31 | $1.75B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $3.35B derived: sum of 2 quarters · filed 2024-02-14 | $4.85B derived: sum of 3 quarters · filed 2024-02-14 | $6.43B 10-K · filed 2024-02-14 | ||||
| 2021-09-30 | $1.60B 10-Q · filed 2022-11-01 | $3.11B derived: sum of 2 quarters · filed 2022-11-01 | $4.68B 10-Q · filed 2022-11-01 | $6.24B derived: sum of 4 quarters · filed 2023-02-10 | ||||
| 2021-06-30 | $1.50B 10-Q · filed 2022-07-27 | $3.08B 10-Q · filed 2022-07-27 | $4.64B derived: sum of 3 quarters · filed 2023-02-10 | $5.89B derived: sum of 4 quarters · filed 2023-02-10 | ||||
| 2021-03-31 | $1.57B 10-Q · filed 2022-04-29 | $3.14B derived: sum of 2 quarters · filed 2023-02-10 | $4.38B derived: sum of 3 quarters · filed 2023-02-10 | $5.61B derived: sum of 4 quarters · filed 2023-02-10 | ||||
| 2020-12-31 | $1.56B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $2.81B derived: sum of 2 quarters · filed 2023-02-10 | $4.03B derived: sum of 3 quarters · filed 2023-02-10 | $5.36B 10-K · filed 2023-02-10 | ||||
| 2020-09-30 | $1.24B 10-Q · filed 2021-10-29 | $2.47B derived: sum of 2 quarters · filed 2021-10-29 | $3.80B 10-Q · filed 2021-10-29 | $5.18B derived: sum of 4 quarters · filed 2022-02-11 | ||||
| 2020-06-30 | $1.23B 10-Q · filed 2021-07-28 | $2.56B 10-Q · filed 2021-07-28 | $3.94B derived: sum of 3 quarters · filed 2022-02-11 | $5.23B derived: sum of 4 quarters · filed 2022-02-11 | ||||
| 2020-03-31 | $1.33B 10-Q · filed 2021-04-28 | $2.71B derived: sum of 2 quarters · filed 2022-02-11 | $4.00B derived: sum of 3 quarters · filed 2022-02-11 | $5.28B derived: sum of 4 quarters · filed 2022-02-11 | ||||
| 2019-12-31 | $1.38B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $2.67B derived: sum of 2 quarters · filed 2022-02-11 | $3.95B derived: sum of 3 quarters · filed 2022-02-11 | $5.36B 10-K · filed 2022-02-11 | ||||
| 2019-09-30 | $1.29B 10-Q · filed 2020-10-30 | $2.57B derived: sum of 2 quarters · filed 2020-10-30 | $3.98B 10-Q · filed 2020-10-30 | $5.41B derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-06-30 | $1.28B 10-Q · filed 2020-07-31 | $2.69B 10-Q · filed 2020-07-31 | $4.12B derived: sum of 3 quarters · filed 2021-02-11 | $5.36B derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-03-31 | $1.40B 10-Q · filed 2020-05-01 | $2.83B derived: sum of 2 quarters · filed 2021-02-11 | $4.08B derived: sum of 3 quarters · filed 2021-02-11 | $5.27B derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2018-12-31 | $1.43B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $2.67B derived: sum of 2 quarters · filed 2021-02-11 | $3.86B derived: sum of 3 quarters · filed 2021-02-11 | $5.10B 10-K · filed 2021-02-11 | ||||
| 2018-09-30 | $1.24B 10-Q · filed 2019-10-30 | $2.43B derived: sum of 2 quarters · filed 2019-10-30 | $3.67B 10-Q · filed 2019-10-30 | $4.88B derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-06-30 | $1.19B 10-Q · filed 2019-07-26 | $2.43B 10-Q · filed 2019-07-26 | $3.64B derived: sum of 3 quarters · filed 2020-02-06 | $4.75B derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-03-31 | $1.24B 10-Q · filed 2019-04-24 | $2.45B derived: sum of 2 quarters · filed 2020-02-06 | $3.56B derived: sum of 3 quarters · filed 2020-02-06 | $4.69B derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2017-12-31 | $1.22B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $2.32B derived: sum of 2 quarters · filed 2020-02-06 | $3.45B derived: sum of 3 quarters · filed 2020-02-06 | $4.55B 10-K · filed 2020-02-06 | ||||
| 2017-09-30 | $1.10B 10-Q · filed 2018-10-26 | $2.23B derived: sum of 2 quarters · filed 2018-10-26 | $3.33B 10-Q · filed 2018-10-26 | $4.43B derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2017-06-30 | $1.13B 10-Q · filed 2018-07-25 | $2.23B 10-Q · filed 2018-07-25 | $3.33B derived: sum of 3 quarters · filed 2019-02-07 | $4.38B derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2017-03-31 | $1.10B 10-Q · filed 2018-04-27 | $2.19B derived: sum of 2 quarters · filed 2019-02-07 | $3.25B derived: sum of 3 quarters · filed 2019-02-07 | $4.29B derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2016-12-31 | $1.09B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-07 | $2.15B derived: sum of 2 quarters · filed 2019-02-07 | $3.19B derived: sum of 3 quarters · filed 2019-02-07 | $4.14B 10-K · filed 2019-02-07 | ||||
| 2016-09-30 | $1.06B 10-Q · filed 2017-10-27 | $2.10B derived: sum of 2 quarters · filed 2017-10-27 | $3.04B 10-Q · filed 2017-10-27 | $4.01B derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2016-06-30 | $1.04B 10-Q · filed 2017-07-28 | $1.99B 10-Q · filed 2017-07-28 | $2.96B derived: sum of 3 quarters · filed 2018-02-08 | $3.84B derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2016-03-31 | $944.00M 10-Q · filed 2017-04-27 | $1.91B derived: sum of 2 quarters · filed 2018-02-08 | $2.80B derived: sum of 3 quarters · filed 2018-02-08 | $3.66B derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2015-12-31 | $970.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-08 | $1.86B derived: sum of 2 quarters · filed 2018-02-08 | $2.72B derived: sum of 3 quarters · filed 2018-02-08 | $3.61B 10-K · filed 2018-02-08 | ||||
| 2015-09-30 | $887.00M 10-Q · filed 2016-10-28 | $1.75B derived: sum of 2 quarters · filed 2016-10-28 | $2.64B 10-Q · filed 2016-10-28 | $3.58B derived: sum of 4 quarters · filed 2017-02-09 | ||||
| 2015-06-30 | $861.00M 10-Q · filed 2016-07-22 | $1.75B 10-Q · filed 2016-07-22 | $2.69B derived: sum of 3 quarters · filed 2017-02-09 | $3.57B derived: sum of 4 quarters · filed 2017-02-09 | ||||
| 2015-03-31 | $892.00M 10-Q · filed 2016-04-22 | $1.83B derived: sum of 2 quarters · filed 2017-02-09 | $2.71B derived: sum of 3 quarters · filed 2017-02-09 | $3.58B derived: sum of 4 quarters · filed 2017-02-09 | ||||
| 2014-12-31 | $940.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-09 | $1.82B derived: sum of 2 quarters · filed 2017-02-09 | $2.69B derived: sum of 3 quarters · filed 2017-02-09 | $3.55B 10-K · filed 2017-02-09 | $3.58B 10-K · filed 2015-02-12 | |||
| 2014-09-30 | $878.00M 10-Q · filed 2015-10-23 | $910.00M 10-Q · filed 2014-10-23 | $1.75B derived: sum of 2 quarters · filed 2015-10-23 | $2.61B 10-Q · filed 2015-10-23 | $3.26B 10-Q · filed 2014-10-23 | $3.01B derived: sum of 4 quarters · filed 2016-02-11 | ||
| 2014-06-30 | $870.00M 10-Q · filed 2015-07-29 | $1.15B 10-Q · filed 2014-07-24 | $1.73B 10-Q · filed 2015-07-29 | $2.35B 10-Q · filed 2014-07-24 | $2.13B derived: sum of 3 quarters · filed 2016-02-11 | $3.27B derived: sum of 4 quarters · filed 2016-02-11 | ||
| 2014-03-31 | $859.00M 10-Q · filed 2015-04-30 | $1.21B 10-Q · filed 2014-04-24 | $1.26B derived: sum of 2 quarters · filed 2016-02-11 | $2.40B derived: sum of 3 quarters · filed 2016-02-11 | $3.41B derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2013-12-31 | $400.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $1.54B derived: sum of 2 quarters · filed 2016-02-11 | $2.55B derived: sum of 3 quarters · filed 2016-02-11 | $3.47B 10-K · filed 2016-02-11 | $4.07B 10-K · filed 2014-02-13 | |||
| 2013-09-30 | $1.14B 10-Q · filed 2014-10-23 | $2.15B derived: sum of 2 quarters · filed 2014-10-23 | $3.07B 10-Q · filed 2014-10-23 | $4.00B derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-06-30 | $1.01B 10-Q · filed 2014-07-24 | $1.93B 10-Q · filed 2014-07-24 | $2.87B derived: sum of 3 quarters · filed 2015-02-12 | $3.66B derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-03-31 | $916.00M 10-Q · filed 2014-04-24 | $1.85B derived: sum of 2 quarters · filed 2015-02-12 | $2.64B derived: sum of 3 quarters · filed 2015-02-12 | $3.46B derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2012-12-31 | $934.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | $1.73B derived: sum of 2 quarters · filed 2015-02-12 | $2.55B derived: sum of 3 quarters · filed 2015-02-12 | $3.37B 10-K · filed 2015-02-12 | $3.47B 10-K · filed 2013-02-27 | |||
| 2012-09-30 | $791.00M 10-Q · filed 2013-10-23 | $1.61B derived: sum of 2 quarters · filed 2013-10-23 | $2.43B 10-Q · filed 2013-10-23 | $3.27B derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2012-06-30 | $823.00M 10-Q · filed 2013-07-23 | $1.64B 10-Q · filed 2013-07-23 | $2.48B derived: sum of 3 quarters · filed 2014-02-13 | $3.24B derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2012-03-31 | $819.00M 10-Q · filed 2013-04-30 | $1.65B derived: sum of 2 quarters · filed 2014-02-13 | $2.42B derived: sum of 3 quarters · filed 2014-02-13 | $3.20B derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2011-12-31 | $834.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-13 | $1.60B derived: sum of 2 quarters · filed 2014-02-13 | $2.38B derived: sum of 3 quarters · filed 2014-02-13 | $3.15B 10-K · filed 2014-02-13 | ||||
| 2011-09-30 | $765.00M 10-Q · filed 2012-10-22 | $1.55B derived: sum of 2 quarters · filed 2012-10-22 | $2.32B 10-Q · filed 2012-10-22 | $3.05B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | $786.00M 10-Q · filed 2012-07-24 | $785.80M 10-Q · filed 2011-07-28 | $1.55B 10-Q · filed 2012-07-24 | $2.29B derived: sum of 3 quarters · filed 2013-02-27 | $2.93B derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2011-03-31 | $765.00M 10-Q · filed 2012-04-24 | $765.20M 10-Q · filed 2011-05-04 | $1.50B derived: sum of 2 quarters · filed 2013-02-27 | $2.14B derived: sum of 3 quarters · filed 2013-02-27 | $2.80B derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2010-12-31 | $734.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $1.38B derived: sum of 2 quarters · filed 2013-02-27 | $2.04B derived: sum of 3 quarters · filed 2013-02-27 | $2.71B 10-K · filed 2013-02-27 | $2.71B 10-K · filed 2011-02-18 | |||
| 2010-09-30 | $643.00M 10-Q · filed 2011-10-28 | $643.30M 10-Q · filed 2010-11-04 | $1.30B derived: sum of 2 quarters · filed 2011-10-28 | $1.97B 10-Q · filed 2011-10-28 | $1.97B 10-Q · filed 2010-11-04 | $2.60B derived: sum of 4 quarters · filed 2012-02-13 | ||
| 2010-06-30 | $661.80M 10-Q · filed 2011-07-28 | $1.33B 10-Q · filed 2011-07-28 | $1.96B derived: sum of 3 quarters · filed 2012-02-13 | $2.60B derived: sum of 4 quarters · filed 2012-02-13 | ||||
| 2010-03-31 | $667.80M 10-Q · filed 2011-05-04 | $1.30B derived: sum of 2 quarters · filed 2012-02-13 | $1.94B derived: sum of 3 quarters · filed 2012-02-13 | $2.56B derived: sum of 4 quarters · filed 2012-02-13 | ||||
| 2009-12-31 | $628.40M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-13 | $1.27B derived: sum of 2 quarters · filed 2012-02-13 | $1.89B derived: sum of 3 quarters · filed 2012-02-13 | $2.51B 10-K · filed 2012-02-13 | $2.51B 10-K · filed 2010-02-26 | |||
| 2009-09-30 | $643.90M 10-Q · filed 2010-11-04 | $1.26B derived: sum of 2 quarters · filed 2010-11-04 | $1.88B 10-Q · filed 2010-11-04 | $2.53B derived: sum of 4 quarters · filed 2011-02-18 | ||||
| 2009-06-30 | $617.10M 10-Q · filed 2010-08-09 | $1.23B 10-Q · filed 2010-08-09 | $1.88B derived: sum of 3 quarters · filed 2011-02-18 | $2.53B derived: sum of 4 quarters · filed 2011-02-18 | ||||
| 2009-03-31 | $616.60M 10-Q · filed 2010-04-29 | $1.26B derived: sum of 2 quarters · filed 2011-02-18 | $1.91B derived: sum of 3 quarters · filed 2011-02-18 | $2.59B derived: sum of 4 quarters · filed 2011-02-18 | ||||
| 2008-12-31 | $647.60M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | $1.29B derived: sum of 2 quarters · filed 2011-02-18 | $1.97B derived: sum of 3 quarters · filed 2011-02-18 | $2.63B 10-K · filed 2011-02-18 | ||||
| 2008-09-30 | $644.80M 10-Q · filed 2009-11-09 | $1.32B derived: sum of 2 quarters · filed 2009-11-09 | $1.98B 10-Q · filed 2009-11-09 | |||||
| 2008-06-30 | $678.20M 10-Q/A · filed 2009-09-03 | $1.33B 10-Q/A · filed 2009-09-03 | ||||||
| 2007-12-31 | $2.39B 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |